In this article we will introduce new biochemical technologies to combat viral diseases. Before introducing this technique, it is first necessary to understand the origin of the disease. Most diseases are caused by bacteria and viruses. Long ago, antibiotics were discovered and they had the ability to kill bacteria. However, there is no such a powerful way to treat viral infections. In this article, we will first explain the principle of penicillin and HIV protease inhibitor's operation, and then propose application of learning enzyme mechanism to treat viral diseases.
NICHOLAS V. EMANUELE, MD, Director of Drug Research and Molecular Biology, Endocrinology and Metabolism Department, Medicine Faculty, Loyola University, Maywood, Illinois. And a staff doctor at Vineyard Hospital of Haynes, Illinois. At least 90% of cases. Type 1 diabetes is a disease in which the immune system of the body not only attacks and destroys foreign molecules and organs but also destroys certain cells of the body. In most patients, the disease develops predominantly in childhood or adolescence, before age 40. In these patients, the immune system attacks specific cells of the pancreas (called beta cells). (For details on the structure and function of the pancreas, see the text box on page 213.)
Bioinformatics promotes advances in genetics, proteomics, artificial intelligence and machine learning, and molecular biology. Bioinformatics methods are used to understand gene function, cell regulation, drug target selection, drug design, and disease. It is impossible to interpret or utilize biological and genomic data without quantitative analysis of large amounts of biological data generated by various systems. Large enterprises such as pharmaceutical companies hire bioinformatics scientists to implement and maintain large and complex bioinformatics needs in these industries. Along with the growing demand for bioinformatics experts, most biomedical laboratories may soon have their own bioinformatics. In addition to the basic acquisition and analysis of simple data, individual researchers certainly need external bioinformatics advice for complex analysis.